BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Clinical Outcome
73 results:

  • 1. clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis.
    Epistolio S; Dazio G; Zaed I; Sahnane N; Cipriani D; Polinelli F; Barizzi J; Spina P; Stefanini FM; Cerati M; Balbi S; Mazzucchelli L; Sessa F; Pesce GA; Reinert M; Cardia A; Marchi F; Frattini M
    Cells; 2024 Feb; 13(3):. PubMed ID: 38334668
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular and clinicopathological implications of PRAME expression in adult glioma.
    Le MK; Vuong HG; Dunn IF; Kondo T
    PLoS One; 2023; 18(10):e0290542. PubMed ID: 37796789
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Higher Mixed lineage Kinase Domain-like protein (MLKL) is associated with worst overall survival in adult-type diffuse glioma patients.
    Vergara GA; Eugenio GC; Fleury Malheiros SM; Victor EDS; Weinlich R
    PLoS One; 2023; 18(8):e0291019. PubMed ID: 37651429
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. lncRNA TRHDE-AS1 Correlated with Genomic Landscape and clinical outcome in Glioma.
    Xie J; Lin Y; Li Y; Fang A; Li X; Wang S; Li W
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239411
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. IRX1 is a novel gene, overexpressed in high-grade idh-mutant astrocytomas.
    Sugur HS; Rao S; Sravya P; Athul Menon K; Arivazhagan A; Mehta B; Santosh V
    Pathol Res Pract; 2023 May; 245():154464. PubMed ID: 37116364
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation.
    Lakis NS; Brodsky AS; Karashchuk G; Audesse AJ; Yang D; Sturtevant A; Lombardo K; Wong IY; Webb AE; Anthony DC
    Acta Neuropathol Commun; 2022 Nov; 10(1):159. PubMed ID: 36333778
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TSPO PET signal using [
    Quach S; Holzgreve A; Kaiser L; Unterrainer M; Dekorsy FJ; Nelwan DV; Bartos LM; Kirchleitner SV; Weller J; Weidner L; Niyazi M; Ruf VC; Herms J; Stöcklein S; Wetzel C; Riemenschneider MJ; V Baumgarten L; Thon N; Brendel M; Rupprecht R; Bartenstein P; Tonn JC; Albert NL
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):859-869. PubMed ID: 36329288
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Global DNA methylation profiling reveals chromosomal instability in idh-mutant astrocytomas.
    Liu Y; Sathe AA; Abdullah KG; McBrayer SK; Adams SH; Brenner AJ; Hatanpaa KJ; Viapiano MS; Xing C; Walker JM; Richardson TE
    Acta Neuropathol Commun; 2022 Mar; 10(1):32. PubMed ID: 35264242
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.
    Pratt D; Abdullaev Z; Papanicolau-Sengos A; Ketchum C; Panneer Selvam P; Chung HJ; Lee I; Raffeld M; Gilbert MR; Armstrong TS; Pytel P; Borys E; Klonoski JM; McCord M; Horbinski C; Brat D; Perry A; Solomon D; Eberhart C; Giannini C; Quezado M; Aldape K
    Acta Neuropathol; 2022 Mar; 143(3):403-414. PubMed ID: 35103816
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in idh wild-type lower-grade gliomas in adult patients.
    Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z
    Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Subventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers.
    Karschnia P; Weller J; Blobner J; Stoecklein VM; Dorostkar MM; Rejeski K; Forbrig R; Niyazi M; von Baumgarten L; Dietrich J; Tonn JC; Thon N
    Sci Rep; 2021 Oct; 11(1):20045. PubMed ID: 34625590
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas.
    Ferreyra Vega S; Olsson Bontell T; Corell A; Smits A; Jakola AS; Carén H
    Clin Epigenetics; 2021 May; 13(1):102. PubMed ID: 33941250
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular Signatures of Chromosomal Instability Correlate With Copy Number Variation Patterns and Patient outcome in idh-Mutant and idh-Wildtype Astrocytomas.
    Richardson TE; Sathe AA; Xing C; Mirchia K; Viapiano MS; Snuderl M; Abdullah KG; Hatanpaa KJ; Walker JM
    J Neuropathol Exp Neurol; 2021 Mar; 80(4):354-365. PubMed ID: 33755138
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
    Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
    J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Primary mismatch repair deficient idh-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
    Suwala AK; Stichel D; Schrimpf D; Kloor M; Wefers AK; Reinhardt A; Maas SLN; Kratz CP; Schweizer L; Hasselblatt M; Snuderl M; Abedalthagafi MSJ; Abdullaev Z; Monoranu CM; Bergmann M; Pekrun A; Freyschlag C; Aronica E; Kramm CM; Hinz F; Sievers P; Korshunov A; Kool M; Pfister SM; Sturm D; Jones DTW; Wick W; Unterberg A; Hartmann C; Dodgshun A; Tabori U; Wesseling P; Sahm F; von Deimling A; Reuss DE
    Acta Neuropathol; 2021 Jan; 141(1):85-100. PubMed ID: 33216206
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival.
    Dejaegher J; Solie L; Hunin Z; Sciot R; Capper D; Siewert C; Van Cauter S; Wilms G; van Loon J; Ectors N; Fieuws S; Pfister SM; Van Gool SW; De Vleeschouwer S
    Neuro Oncol; 2021 Feb; 23(2):240-250. PubMed ID: 33130898
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. idh clonal heterogeneity segregates a subgroup of non-1p/19q codeleted gliomas with unfavourable clinical outcome.
    Luo S; Zhu S; Liao J; Zhang Y; Hou X; Luo T; Zhao E; Xu J; Pang L; Liang X; Xiao Y; Li X
    Neuropathol Appl Neurobiol; 2021 Apr; 47(3):394-405. PubMed ID: 33098109
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With clinical outcome and Survival Analysis: A Prospective, Single Institution, Case Series.
    Certo F; Altieri R; Maione M; Schonauer C; Sortino G; Fiumanò G; Tirrò E; Massimino M; Broggi G; Vigneri P; Magro G; Visocchi M; Barbagallo GMV
    Oper Neurosurg (Hagerstown); 2021 Jan; 20(2):151-163. PubMed ID: 33035343
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Infratentorial idh-mutant astrocytoma is a distinct subtype.
    Banan R; Stichel D; Bleck A; Hong B; Lehmann U; Suwala A; Reinhardt A; Schrimpf D; Buslei R; Stadelmann C; Ehlert K; Prinz M; Acker T; Schittenhelm J; Kaul D; Schweizer L; Capper D; Harter PN; Etminan N; Jones DTW; Pfister SM; Herold-Mende C; Wick W; Sahm F; von Deimling A; Hartmann C; Reuss DE
    Acta Neuropathol; 2020 Oct; 140(4):569-581. PubMed ID: 32776277
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.